BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

347 related articles for article (PubMed ID: 19017737)

  • 1. Cardiovascular injury and repair in chronic obstructive pulmonary disease.
    Macnee W; Maclay J; McAllister D
    Proc Am Thorac Soc; 2008 Dec; 5(8):824-33. PubMed ID: 19017737
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiovascular disease in COPD: mechanisms.
    Maclay JD; MacNee W
    Chest; 2013 Mar; 143(3):798-807. PubMed ID: 23460157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. β-Blocker Therapy and Clinical Outcomes in Patients with Moderate Chronic Obstructive Pulmonary Disease and Heightened Cardiovascular Risk. An Observational Substudy of SUMMIT.
    Dransfield MT; McAllister DA; Anderson JA; Brook RD; Calverley PMA; Celli BR; Crim C; Gallot N; Martinez FJ; Scanlon PD; Yates J; Vestbo J; Newby DE;
    Ann Am Thorac Soc; 2018 May; 15(5):608-614. PubMed ID: 29406772
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early cardiovascular involvement in chronic obstructive pulmonary disease.
    Malerba M; Romanelli G
    Monaldi Arch Chest Dis; 2009 Jun; 71(2):59-65. PubMed ID: 19719036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Chronic obstructive pulmonary disease and cardiovascular disease: role of the systemic inflammation].
    Rossi FF; Pedone C; Antonelli Incalzi R
    Recenti Prog Med; 2011 Mar; 102(3):109-13. PubMed ID: 21572482
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chronic obstructive pulmonary disease: a modifiable risk factor for cardiovascular disease?
    Stone IS; Barnes NC; Petersen SE
    Heart; 2012 Jul; 98(14):1055-62. PubMed ID: 22739636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Murine models of cardiovascular comorbidity in chronic obstructive pulmonary disease.
    Khedoe PP; Rensen PC; Berbée JF; Hiemstra PS
    Am J Physiol Lung Cell Mol Physiol; 2016 Jun; 310(11):L1011-27. PubMed ID: 26993520
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COPD and stroke: are systemic inflammation and oxidative stress the missing links?
    Austin V; Crack PJ; Bozinovski S; Miller AA; Vlahos R
    Clin Sci (Lond); 2016 Jul; 130(13):1039-50. PubMed ID: 27215677
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Seasonal and Regional Variations in Chronic Obstructive Pulmonary Disease Exacerbation Rates in Adults without Cardiovascular Risk Factors.
    So JY; Zhao H; Voelker H; Reed RM; Sin D; Marchetti N; Criner GJ
    Ann Am Thorac Soc; 2018 Nov; 15(11):1296-1303. PubMed ID: 30063372
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic obstructive pulmonary disease and obstructive sleep apnea: overlaps in pathophysiology, systemic inflammation, and cardiovascular disease.
    McNicholas WT
    Am J Respir Crit Care Med; 2009 Oct; 180(8):692-700. PubMed ID: 19628778
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chronic obstructive pulmonary disease and cardiovascular disease.
    Bhatt SP; Dransfield MT
    Transl Res; 2013 Oct; 162(4):237-51. PubMed ID: 23727296
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Chronic obstructive pulmonary disease and cardiovascular system].
    Gürgün A; Gürgün C
    Tuberk Toraks; 2008; 56(4):464-71. PubMed ID: 19123087
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New frontiers in the treatment of comorbid cardiovascular disease in chronic obstructive pulmonary disease.
    Brassington K; Selemidis S; Bozinovski S; Vlahos R
    Clin Sci (Lond); 2019 Apr; 133(7):885-904. PubMed ID: 30979844
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Systemic effects of chronic obstructive pulmonary disease.
    Agustí AG
    Proc Am Thorac Soc; 2005; 2(4):367-70; discussion 371-2. PubMed ID: 16267364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myocardial perfusion reserve is impaired in patients with chronic obstructive pulmonary disease: a comparison to current smokers.
    Nakamori S; Onishi K; Ishida M; Nakajima H; Yamada T; Nagata M; Kitagawa K; Dohi K; Nakamura M; Sakuma H; Ito M
    Eur Heart J Cardiovasc Imaging; 2014 Feb; 15(2):180-8. PubMed ID: 23839654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiovascular Outcomes and All-Cause Mortality in Patients with Obstructive Sleep Apnea and Chronic Obstructive Pulmonary Disease (Overlap Syndrome).
    Kendzerska T; Leung RS; Aaron SD; Ayas N; Sandoz JS; Gershon AS
    Ann Am Thorac Soc; 2019 Jan; 16(1):71-81. PubMed ID: 30372124
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular risk in chronic obstructive pulmonary disease.
    Maclay JD; McAllister DA; Macnee W
    Respirology; 2007 Sep; 12(5):634-41. PubMed ID: 17875049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chronic obstructive pulmonary disease: a novel risk factor for cardiovascular disease.
    Sin DD; Man SF
    Can J Physiol Pharmacol; 2005 Jan; 83(1):8-13. PubMed ID: 15759045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Systemic inflammation and mortality in chronic obstructive pulmonary disease.
    Sin DD; Man SF
    Can J Physiol Pharmacol; 2007 Jan; 85(1):141-7. PubMed ID: 17487253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Determinants of endothelial function in patients with COPD.
    Clarenbach CF; Senn O; Sievi NA; Camen G; van Gestel AJ; Rossi VA; Puhan MA; Thurnheer R; Russi EW; Kohler M
    Eur Respir J; 2013 Nov; 42(5):1194-204. PubMed ID: 23429917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.